top of page

featured Products


Myopia, also known as short-sightedness, is becoming a serious problem in more and more countries. In urban areas of Asia, almost 90% of young people develop myopia before the age of 20 – a trend that continues worldwide.


Studies predict that, by the year 2050, nearly 50 percent of the world's population could be shortsighted. In a worst-case scenario, early myopia can lead to the emergence of progressive myopia, a severe form of short-sightedness. This increases the risk of other eye problems, such as damage to the retina or even blindness.

Development of Myopia in children


Screenshot 2021-03-17 at 9.12.43 PM.png

Cooper Vision MISIGHT® 1 day is the world’s first soft daily disposable contact lens proven to significantly slow the progression of myopia in children. 

The Myopia Management System is a holistic approach to minimising the progression of myopia by combining MiSight contact lenses with ActivControl™ Technology and strategies for better eye health.

Winner: 'Contact Lens Product of the Year’ at the prestigious 2018 Optician Awards.

Winner: ‘Best of What’s New Award’ at the 2020 Popular Science, in the health category. 


ZEISS MyoCare is the latest myopia management lens from ZEISS. It is also the first age-related myopia management lens solution.  Backed by ZEISS innovation and more than a decade of experience in developing lenses aimed to manage myopia progression, Myocare features C.A.R.E.® technology (Cylindrical Annular Refractive Elements). C.A.R.E.® :

  • aims to deliver a `stop signal' to slow down progression of axial elongation; 

  • consists of alternating defocus and correction zones in a ring-like pattern on the front surface, expanding towards the periphery of the lens;

  • aims to remove the `growth signal';

  • has back surface which delivers the refractive correction and intended myopic defocus of the patient for all gaze directions.

Screenshot 2023-06-23 09.38.34.png


HOYA's revolutionary spectacle lens based on patented Defocus Incorporated Multiple Segments (D.I.M.S.) Technology was developed in cooperation with The Hong Kong Polytechnic University in 2014.

With the exclusive non-invasive D.I.M.S. Technology, the lens corrects the visual defect on its entire surface and has a ring shaped treatment area to slow down myopia progression. The alternation of the focus area and defocus area provides clear vision and manages myopia simultaneously.

Screenshot 2022-03-05 23.41_edited.jpg


Essilor® Stellest™ lens is one of the newest generation of myopia-controlling spectacle lenses, appearing to have efficacy to slow myopia progression in children at least as good as the current 'best' interventions of orthokeratology, dual-focus soft contact lenses, and 0.05% atropine.


Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.


Using H.A.L.T. (Highly Aspherical Lenslet Target) technology, Stellest™ lenses create a signal that acts as a shield to slow down myopia progression.

Stellest Frame 580 x 380 copy.jpg
bottom of page